1. [SCIE] Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy [ANNALS OF HEMATOLOGY] - 2024-07-01 2. [SCIE] Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation [Frontiers in Oncology] - 2023-08-22 3. [SCIE] LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells [PLoS One] - 2023-08-08 4. [SCIE] A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea [EXPERT OPINION ON BIOLOGICAL THERAPY] - 2023-07-01 5. [SCIE] The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation [BMC CANCER] - 2022-09-20